Member Info for PL75

‘he was one of the good guys, he has a lot of followers’

Incompatible statements. He’s a trader and posts to his advantage. He also posts a lot of really stupid stuff, that being an example. The idea is right, get an investor on board as part of the move to Nasdaq, it’s in the playbook they’re following. His dramatic deadline setting is ridiculous though. Dx will be sold, there aren’t any cash dramas, they’ve got plenty runway.

Popped by, I see eggy is still haunting the board. Meanwhile, MATD has managed a dead cat bounce off its all time lows. Couldn't happen to a scummier troll. Merry xmas all xx

Ask him if he fancies donating $55m to help cure cancer

JES, it's a straightforward path to greatness. Tidy up the group, get on Nasdaq, specialist investor to strengthen the bank balance (with dilution - OMG, FUD!), maybe bin off the HCI loan at that point. They're then sat with valuable assets plodding through the clinic. Just a case of who blinks first.

I've watched it - and it's the reason this board is a waste of time. They're following the exact playbook so bickering with morons isn't worth any effort.

They've left. That's why it's available. Anyone know what happened to Alan's old house? I love irrelevant property info.

Yeah, no Q&A, that was the bit I was mainly interested in. I already know the scientists have done some very clever sciency things that are worth untold fortunes, I wanted the goss.

I also heard the same rumour. Reliable sauce. 18:36 yesterday.

Come on BV, have a whinge. They need to update the diagnostics page as it still says they're actively pursuing an M&A led growth strategy. Much much worse than that, they're still using the old corporate red colours on that page.

Bluesy, top tip, you can't give drugs to dead people. Big farmer needs a living population to make money, keeping them alive is quite important. Don't worry, there'll be plenty misery, and billions, to go around. Awful argument.

Exactly WAG. It's more like a flock of birds migrating south for winter who, despite having the entirety of the UK to aim at, still manage to sh.t on my car.

I asked ChatGPT how much is typically given in b2 raises….

In biotech, Series B2 funding rounds are less common than Series B rounds, but they typically occur when a company requires additional capital before reaching Series C or preparing for clinical trials. Equity given away in these rounds can vary, but it generally depends on the company’s stage, valuation, and investor negotiations. Here are a few examples and typical equity percentages in biotech:

1. **Graphite Bio (2021)**: In its Series B round, the gene-editing company raised about $150 million, with an estimated equity dilution of around 20-25%. This is typical when raising larger amounts for scaling research and clinical preparations in biotech.

2. **Immunocore (2020)**: In its Series B and B2 rounds, Immunocore raised $130 million to advance its T-cell receptor-based therapies. The specific equity given away was not disclosed, but similar rounds in the industry generally see about 10-30% equity offered depending on valuation and funding stage.

3. **Codiak BioSciences (2019)**: During its Series B and later B2 rounds, Codiak raised over $150 million, giving away an estimated 20-30% equity. The high valuation of Codiak's exosome platform allowed them to avoid excessive dilution while securing the capital needed for pre-clinical trials.

Typically, for Series B rounds (including B2), biotech companies may give up **10-30% equity** to investors. The specific percentage often depends on the company's pre-money valuation and the stage of clinical or pre-clinical trials.

Say 20%. $150m. Values the company at $750m, but it would unlock getting ava6k for STS to market, maybe P2 for breast, next gen to the clinic and they could pay the CLN in cash. Sounds good to me.

Good post Muck. Likewise, I’m less interested in the detail, It Works (tm). That’s all that matters ultimately. It’ll be a shame if the video doesn’t turn up, not for the science stuff - It Works (tm), let the team in lab coats suss that out. I was interested in the q&a. If all we get is JTs write up, then many thanks to him, it’s appreciated.

I feel sorry for your chiropodist

I couldn't concentrate on it. Some of the paragraph spacings were a couple of mm out and on one of the slides the margins weren't symmetrical.

Ugh, yeah, I hate it when they present science stuff on science days, especially when there are numerous crayon wielding experts that could have scrawled much better content for us on their sweaty basement walls.

"We believe in slides without videos"

They wouldn't let me in. Or more accurately, they wouldn't let in my 20 squad media crew to record everything.

What about the chat whilst they enjoyed their tuna sandwiches? Did everyone have to wear a bodycam? I'll guarantee there was more said than in the 2 hours.

They're suppressing release of the video to let the IIs out before the bad news sinks the SP. Either that or they have no respect for their ordinary investors who couldn't make it to the presentation in person ASAP.

You've since posted that the presentation was a repeat of the 2 recent poster presentations. So your first sentence is mental. Second sentence, you constantly berate everything they put out - so you're aware they're not a media company and they probably can't afford the luxury of a inhouse video editor with Premier Pro. I suspect the delay is because they've had to post the Betamax tapes to a third party to edit.